Page 10 - NewsletterVol2
P. 10

A main Deliverable of the WP is a Catalogue of existing clinical data appropriate to provide

         WP8      information on the quality and safety of human blood, cell, and tissue therapeutics once
                  applied to patients, under the conditions of current state-of-the-art processing and testing
                  protocols. The Deliverable has been finalized.
                  Another Deliverable of this WP is a catalogue of risk-based set of criteria, appropriate to
                  evaluate the established catalogue of clinical data for completeness and suitability in case of
                  introduction of innovation to the current processing and testing protocols for human blood,
                  cell, and tissue therapeutics. This Deliverable is currently being drafted by the WP8 leaders.
                  Finally, the structure of a third Deliverable of this WP has been drafted and two subgroups
                  of invited experts and collaborating beneficiaries will start working on that. This Deliverable
                  concerns methodological framework to evaluate quality and safety of human blood, cell, and
                  tissue  therapeutics  based  on  clinical  outcome  data  requested  for  authorisation  processes
                  upon introduction of innovation to the current processing and testing protocols for human
                  blood, cell, and tissue therapeutics.





                  KNOWLEDGE SHARING ON PPA BETWEEN EU CAS
         WP9      WP Leader: PEI, Germany
                  Started in May 2019, the WP9 aims at laying the grounds for a future implementation of the
                  criteria  catalogues  resulting  from  WP6  WP7  and  WP8,  thus  allowing  for  a  standardised,
                  electronically supported assessment of quality, safety and efficacy of blood, cells and tissues,
                  in  the  case  of  state-of-the-art  processing  procedures  as  well  as  in  the  case  of  innovative
                  processing  procedures.  A  platform  will  be  generated  that  will  contain  all  the  relevant
                  information like a kind of guidance.
                  It will include knowledge sharing content including a teaching part and an access to Member
                  State assessments.






                  TRAINING COURSES AND MANUAL FOR TRAINING

         WP10     WP Leader: KCBTiK/NCTCB, Poland
                  The work of WP10 is strictly connected to the final results of the WP5, WP6, WP7, WP8 and
                  WP9. On the basis of agreed documents: “Overall Guidance on organization of PPA system”
                  and  technical  annexes,  this  WP  will  organise  training  courses  and  prepare  “Manual  for
                  training CA inspectors that assess and authorize preparation processes of tissue, cell, and
                  blood products”, to disseminate the approach throughout Member States.


















          10 GAPP - Newsletter2
   5   6   7   8   9   10   11   12   13   14   15